Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Depreciation and Depletion (2016 - 2019)

Skinvisible's Depreciation and Depletion history spans 9 years, with the latest figure at $59.0 for Q1 2019.

  • On a quarterly basis, Depreciation and Depletion fell 7.81% to $59.0 in Q1 2019 year-over-year; TTM through Dec 2019 was $59.0, a 66.67% decrease, with the full-year FY2019 number at $118.0, down 51.04% from a year prior.
  • Depreciation and Depletion hit $59.0 in Q1 2019 for Skinvisible, roughly flat from $59.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for SKVI hit a ceiling of $395.0 in Q1 2015 and a floor of -$5.0 in Q2 2018.
  • Historically, Depreciation and Depletion has averaged $185.41 across 5 years, with a median of $81.0 in 2016.
  • Biggest five-year swings in Depreciation and Depletion: rose 17.56% in 2015 and later crashed 106.17% in 2018.
  • Tracing SKVI's Depreciation and Depletion over 5 years: stood at $395.0 in 2015, then tumbled by 79.49% to $81.0 in 2016, then changed by 0.0% to $81.0 in 2017, then dropped by 27.16% to $59.0 in 2018, then changed by 0.0% to $59.0 in 2019.
  • Business Quant data shows Depreciation and Depletion for SKVI at $59.0 in Q1 2019, $59.0 in Q4 2018, and $59.0 in Q3 2018.